Successful Treatment of Fungemia Caused by Cyberlindnera fabianii with Anidulafungin: A Case Report
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Cyberlindnera fabianii (previously known as Hansenula fabianii, Pichia fabianii, and Lindnera fabianii) is a yeast species that forms a biofilm, allowing it to resist azole drugs. In this study, we report a case of fungemia with C. fabianii that was successfully treated with anidulafungin. In this case, the organism was initially misidentified as Candida utilis (with a high probability of 93%, suggesting good identification) using the VITEK 2 yeast identification card (YST ID; bioMérieux, USA). The species responsible for the patient’s fungemia was correctly identified after sequencing the internally transcribed spacer region and the D1/D2 domain of the large subunit (26S) rDNA gene. The CLSI M27-A3 broth microdilution method was used to determine the in vitro antifungal activity of anidulafungin and fluconazole against C. fabianii. The MICs of anidulafungin and fluconazole were found to be 0.03 μg/mL and 2 μg/mL, respectively. The patient recovered after 14 days of anidulafungin treatment. (Ann Clin Microbiol 2015;18:-97)
Abstract
Cyberlindnera fabianii (previously known as Hansenula fabianii, Pichia fabianii, and Lindnera fabianii) is a yeast species that forms a biofilm, allowing it to resist azole drugs. In this study, we report a case of fungemia with C. fabianii that was successfully treated with anidulafungin. In this case, the organism was initially misidentified as Candida utilis (with a high probability of 93%, suggesting good identification) using the VITEK 2 yeast identification card (YST ID; bioMérieux, USA). The species responsible for the patient’s fungemia was correctly identified after sequencing the internally transcribed spacer region and the D1/D2 domain of the large subunit (26S) rDNA gene. The CLSI M27-A3 broth microdilution method was used to determine the in vitro antifungal activity of anidulafungin and fluconazole against C. fabianii. The MICs of anidulafungin and fluconazole were found to be 0.03 μg/mL and 2 μg/mL, respectively. The patient recovered after 14 days of anidulafungin treatment. (Ann Clin Microbiol 2015;18:-97)
참고문헌 (11)
- Kurtzman CP, "Phylogenetic relationships among species of Pichia, Issatchenkia and Williopsis determined from multigene sequence analysis, and the proposal of Barnettozyma gen. nov., Lindnera gen. nov. and Wickerhamomyces gen. nov", FEMS Yeast Res, 8, pp.939~954 (2008)
- Dooley DP, "Prostatitis caused by Hansenula fabianii", J Infect Dis, 161, pp.1040~1041 (1990)
- Yun JW, "Catheter-related bloodstream infection by Lindnera fabianii in a neutropenic patient", J Med Microbiol, 62, pp.922~925 (2013)
- Valenza G, "Identification of Candida fabianii as a cause of lethal septicaemia", Mycoses, 49, pp.331~334 (2006)
- Hamal P, "A case of endocarditis caused by the yeast Pichia fabianii with biofilm production and developed in vitro resistance to azoles in the course of antifungal treatment", Med Mycol, 46, pp.601~605 (2008)
- Kurtzman CP, "Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit(26S)ribosomal DNA gene", J Clin Microbiol, 35, pp.1216~1223 (1997)
- Moriya K, "Treatment of distillery wastewater discharged from beet molasses-spirits production using yeast", J Ferment Bioeng, 69, pp.138~140 (1990)
- Nyanga LK, "Fermentation characteristics of yeasts isolated from traditionally fermented masau(Ziziphus mauritiana)fruits", Int J Food Microbiol, 166, pp.426~432 (2013)
- Mukisa IM, "The dominant microbial community associated with fermentation of Obushera(sorghum and millet beverages)determined by culture-dependent and culture-independent methods", Int J Food Microbiol, 160, pp.1~10 (2012)
- Pappas PG, "Clinical practice guidelines for the management of candidiasis : 2009 update by the Infectious Diseases Society of America", Clin Infect Dis, 48, pp.503~535 (2009)
- CLSI, "Interpretive criteria for identification of bacteria and fungi by DNA target sequencing: approved guideline. CLSI document MM18-A", Clinical and Laboratory Standards Institute, ~ (2008)